Patents by Inventor Ryan Olivera

Ryan Olivera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11937913
    Abstract: A method for determining lung function in a patient is disclosed, in which a multi-lumen catheter with an expandable occluding element at its end is used to isolate a targeted lung compartment, and respiratory characteristics at the targeted lung compartment are measured over multiple respiratory cycles. The relation between various characteristics of the respiratory cycle is used to determine compliance of lung tissue within the targeted lung compartment.
    Type: Grant
    Filed: April 23, 2020
    Date of Patent: March 26, 2024
    Assignee: Pulmonx Corporation
    Inventors: Srikanth Radhakrishnan, Surag Mantri, Ryan Olivera
  • Patent number: 11911145
    Abstract: Methods and systems for determining collateral ventilation are disclosed. Methods may comprise introducing a diagnostic catheter into a lung compartment via an assisted ventilation device, inflating the occluding member to isolate the lung compartment, and performing a diagnostic procedure with the catheter while the patient is ventilated via the assisted ventilation device. The diagnostic procedure comprises determining an exhaled volume from the isolated lung compartment over a predetermined period of time while the patient is ventilated via the assisted ventilation device. The presence collateral ventilation may be determined based on the exhaled volume from the isolated lung compartment over the predetermined period of time.
    Type: Grant
    Filed: June 30, 2021
    Date of Patent: February 27, 2024
    Assignee: Pulmonx Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Publication number: 20240008874
    Abstract: Devices, methods, and systems are provided for occluding a collateral flow channel between a target lung compartment and an adjacent lung compartment. A video-assisted thoracoscopic device is inserted into a thoracic cavity of a patient and positioned at a fissure between a target lung compartment and an adjacent lung compartment. A collateral flow channel between the target lung compartment and the adjacent lung compartment is then identified using the video-assisted thoracoscopic device and an agent is injected into the collateral flow channel, thereby reducing the collateral flow channel.
    Type: Application
    Filed: June 8, 2023
    Publication date: January 11, 2024
    Applicant: Pulmonx Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Patent number: 11857406
    Abstract: Disclosed are methods and devices for regulating fluid flow to and from a region of a patient's lung, such as to achieve a desired fluid flow dynamic to a lung region during respiration and/or to induce collapse in one or more lung regions. Pursuant to an exemplary procedure, an identified region of the lung is targeted for treatment. The targeted lung region is then bronchially isolated to regulate airflow into and/or out of the targeted lung region through one or more bronchial passageways that feed air to the targeted lung region. An exemplary flow control device is configured to block fluid flow in the inspiratory direction and the expiratory direction at normal breathing pressures and allow fluid flow in the expiratory direction at higher than normal breathing pressures.
    Type: Grant
    Filed: November 15, 2022
    Date of Patent: January 2, 2024
    Assignee: Pulmonx Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Patent number: 11696763
    Abstract: Devices, methods, and systems are provided for occluding a collateral flow channel between a target lung compartment and an adjacent lung compartment. A video-assisted thoracoscopic device is inserted into a thoracic cavity of a patient and positioned at a fissure between a target lung compartment and an adjacent lung compartment. A collateral flow channel between the target lung compartment and the adjacent lung compartment is then identified using the video-assisted thoracoscopic device and an agent is injected into the collateral flow channel, thereby reducing the collateral flow channel.
    Type: Grant
    Filed: August 6, 2019
    Date of Patent: July 11, 2023
    Assignee: Pulmonx Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Publication number: 20230136081
    Abstract: Disclosed are methods and devices for regulating fluid flow to and from a region of a patient's lung, such as to achieve a desired fluid flow dynamic to a lung region during respiration and/or to induce collapse in one or more lung regions. Pursuant to an exemplary procedure, an identified region of the lung is targeted for treatment. The targeted lung region is then bronchially isolated to regulate airflow into and/or out of the targeted lung region through one or more bronchial passageways that feed air to the targeted lung region. An exemplary flow control device is configured to block fluid flow in the inspiratory direction and the expiratory direction at normal breathing pressures and allow fluid flow in the expiratory direction at higher than normal breathing pressures.
    Type: Application
    Filed: November 15, 2022
    Publication date: May 4, 2023
    Applicant: Pulmonx Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Patent number: 11529224
    Abstract: Disclosed are methods and devices for regulating fluid flow to and from a region of a patient's lung, such as to achieve a desired fluid flow dynamic to a lung region during respiration and/or to induce collapse in one or more lung regions. Pursuant to an exemplary procedure, an identified region of the lung is targeted for treatment. The targeted lung region is then bronchially isolated to regulate airflow into and/or out of the targeted lung region through one or more bronchial passageways that feed air to the targeted lung region. An exemplary flow control device is configured to block fluid flow in the inspiratory direction and the expiratory direction at normal breathing pressures and allow fluid flow in the expiratory direction at higher than normal breathing pressures.
    Type: Grant
    Filed: July 28, 2020
    Date of Patent: December 20, 2022
    Assignee: Pulmonx Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Publication number: 20220184332
    Abstract: The volume of a hyperinflated lung compartment is reduced by sealing a distal end of the catheter in an airway feeding the lung compartment. Air passes out of the lung compartment through a passage in the catheter while the patient exhales. A one-way flow element associated with the catheter prevents air from re-entering the lung compartment as the patient inhales. Over time, the pressure of regions surrounding the lung compartment cause it to collapse as the volume of air diminishes. Residual volume reduction effectively results in functional lung volume expansion. Optionally, the lung compartment may be sealed in order to permanently prevent air from re-entering the lung compartment. The invention further discloses a catheter with a transparent occlusion element at its tip that enables examination of the lung passageway through a viewing scope.
    Type: Application
    Filed: March 7, 2022
    Publication date: June 16, 2022
    Applicant: Pulmonx Corporation
    Inventors: Nikolai Aljuri, Rodney C. Perkins, Ryan Olivera, Hoang Nguyen, Srikanth Radhakrishnan, Niyazi Beyhan
  • Patent number: 11298489
    Abstract: The volume of a hyperinflated lung compartment is reduced by sealing a distal end of the catheter in an airway feeding the lung compartment. Air passes out of the lung compartment through a passage in the catheter while the patient exhales. A one-way flow element associated with the catheter prevents air from re-entering the lung compartment as the patient inhales. Over time, the pressure of regions surrounding the lung compartment cause it to collapse as the volume of air diminishes. Residual volume reduction effectively results in functional lung volume expansion. Optionally, the lung compartment may be sealed in order to permanently prevent air from re-entering the lung compartment. The invention further discloses a catheter with a transparent occlusion element at its tip that enables examination of the lung passageway through a viewing scope.
    Type: Grant
    Filed: May 31, 2019
    Date of Patent: April 12, 2022
    Assignee: Pulmonx Corporation
    Inventors: Nikolai Aljuri, Rodney C. Perkins, Ryan Olivera, Hoang Nguyen, Srikanth Radhakrishnan, Niyazi Beyhan
  • Publication number: 20220044402
    Abstract: Devices, methods, and systems are provided for analyzing lung imaging data. Lung imaging data maybe analyzed to segment the lung, identify fissure locations, calculate fissure defect scores, identify adjacent lung compartments, calculate emphysema scores, calculate volumes, and calculate proximities. Collateral ventilation within a lung compartment may be determined based on the analyzed lung imaging data.
    Type: Application
    Filed: August 3, 2021
    Publication date: February 10, 2022
    Applicant: Pulmonx Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Publication number: 20220007962
    Abstract: Methods and systems for accessing and diagnosing diseased lung compartments are disclosed. Methods may comprise introducing a diagnostic catheter with an occluding member at its distal end into a lung segment; inflating the occluding member to isolate the lung compartment; and performing a diagnostic procedure with the catheter. The proximal end of the diagnostic catheter is configured to be attached to a console. Methods may also include allowing air to enter the lung compartment through the passage in the catheter while the patient is inhaling and blocking air from being expelled from the lung compartment through the catheter passage while the patient is exhaling by using a one-way flow element adapted to be disposed within or in-line with the passage of the catheter so that flow in a proximal-to-distal direction is allowed and flow in a distal-to-proximal direction is inhibited or prevented.
    Type: Application
    Filed: June 30, 2021
    Publication date: January 13, 2022
    Applicant: Pulmonx Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Publication number: 20220007967
    Abstract: Methods and systems for determining collateral ventilation are disclosed. Methods may comprise introducing a diagnostic catheter into a lung compartment via an assisted ventilation device, inflating the occluding member to isolate the lung compartment, and performing a diagnostic procedure with the catheter while the patient is ventilated via the assisted ventilation device. The diagnostic procedure comprises determining an exhaled volume from the isolated lung compartment over a predetermined period of time while the patient is ventilated via the assisted ventilation device. The presence collateral ventilation may be determined based on the exhaled volume from the isolated lung compartment over the predetermined period of time.
    Type: Application
    Filed: June 30, 2021
    Publication date: January 13, 2022
    Applicant: Pulmonx Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Publication number: 20210330441
    Abstract: Devices, methods, and systems are provided for loading an implantable device into a container. One aspect of the loading system contains a loader element with a loading tunnel that is configured to gradually contract an implantable device into a compressed state of reduced size relative to an expanded state as the implantable device travels through the loading tunnel.
    Type: Application
    Filed: July 2, 2021
    Publication date: October 28, 2021
    Applicant: Pulmonx Corporation
    Inventors: Ryan Olivera, Hoang Nguyen
  • Patent number: 11083556
    Abstract: Devices, methods, and systems are provided for loading an implantable device into a container. One aspect of the loading system contains a loader element with a loading tunnel that is configured to gradually contract an implantable device into a compressed state of reduced size relative to an expanded state as the implantable device travels through the loading tunnel.
    Type: Grant
    Filed: June 10, 2019
    Date of Patent: August 10, 2021
    Assignee: Pulmonx Corporation
    Inventors: Ryan Olivera, Hoang Nguyen
  • Publication number: 20210077052
    Abstract: Devices, methods, and systems are provided for analyzing lung imaging data. A server computing device receives imaging data of a lung over a network from a client computing device and analyzes the imaging data to identify lung, airways, and blood vessels, segment the lung into lobes, subtract airways, calculate volumes, calculate emphysema scores, identify fissure locations, calculate fissure completeness scores. A reconstruction of the fissures indicating locations where the fissures are incomplete and a report comprising fissure scores, volumes, and emphysema scores are created.
    Type: Application
    Filed: November 17, 2020
    Publication date: March 18, 2021
    Applicant: PulmonX Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Patent number: 10869647
    Abstract: Devices, methods, and systems are provided for analyzing lung imaging data. A server computing device receives imaging data of a lung over a network from a client computing device and analyzes the imaging data to identify lung, airways, and blood vessels, segment the lung into lobes, subtract airways, calculate volumes, calculate emphysema scores, identify fissure locations, calculate fissure completeness scores. A reconstruction of the fissures indicating locations where the fissures are incomplete and a report comprising fissure scores, volumes, and emphysema scores are created.
    Type: Grant
    Filed: February 3, 2017
    Date of Patent: December 22, 2020
    Assignee: Pulmonx Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Publication number: 20200352696
    Abstract: Disclosed are methods and devices for regulating fluid flow to and from a region of a patient's lung, such as to achieve a desired fluid flow dynamic to a lung region during respiration and/or to induce collapse in one or more lung regions. Pursuant to an exemplary procedure, an identified region of the lung is targeted for treatment. The targeted lung region is then bronchially isolated to regulate airflow into and/or out of the targeted lung region through one or more bronchial passageways that feed air to the targeted lung region. An exemplary flow control device is configured to block fluid flow in the inspiratory direction and the expiratory direction at normal breathing pressures and allow fluid flow in the expiratory direction at higher than normal breathing pressures.
    Type: Application
    Filed: July 28, 2020
    Publication date: November 12, 2020
    Applicant: PulmonX Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Publication number: 20200352695
    Abstract: Devices, systems, and methods for measuring the diameter of an airway in a human or animal subject are disclosed. The device comprises a flexible catheter body having a proximal end and a distal end. Flexible sizing elements are disposed along and extend approximately orthogonally from the catheter body. The sizing elements have different heights from one another and are configured to fit through the working channel of a bronchoscope. Devices, systems, and methods for redirecting airflow through a lung airway are also disclosed. The method comprises introducing into the airway a catheter comprising a distal end, a proximal end and an elongated portion therebetween, wherein the distal end comprises an airway closing mechanism, and wherein the proximal end comprises an actuator to actuate the airway closing mechanism; and actuating the airway closing mechanism to at least partially close the airway.
    Type: Application
    Filed: July 27, 2020
    Publication date: November 12, 2020
    Applicant: PulmonX Corporation
    Inventors: Ryan Olivera, Srikanth Radhakrishnan
  • Publication number: 20200329996
    Abstract: A method for determining lung function in a patient is disclosed, in which a multi-lumen catheter with an expandable occluding element at its end is used to isolate a targeted lung compartment, and respiratory characteristics at the targeted lung compartment are measured over multiple respiratory cycles. The relation between various characteristics of the respiratory cycle is used to determine compliance of lung tissue within the targeted lung compartment.
    Type: Application
    Filed: April 23, 2020
    Publication date: October 22, 2020
    Applicant: Pulmonx Corporation
    Inventors: Srikanth Radhakrishnan, Surag Mantri, Ryan Olivera
  • Patent number: 10758333
    Abstract: Disclosed are methods and devices for regulating fluid flow to and from a region of a patient's lung, such as to achieve a desired fluid flow dynamic to a lung region during respiration and/or to induce collapse in one or more lung regions. Pursuant to an exemplary procedure, an identified region of the lung is targeted for treatment. The targeted lung region is then bronchially isolated to regulate airflow into and/or out of the targeted lung region through one or more bronchial passageways that feed air to the targeted lung region. An exemplary flow control device is configured to block fluid flow in the inspiratory direction and the expiratory direction at normal breathing pressures and allow fluid flow in the expiratory direction at coughing pressures.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: September 1, 2020
    Assignee: Pulmonx Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera